Idamakanti, M., Bijjam, R. I., Kumar, M., & Mukkamalla, S. K. (2025). Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review. Journal of Medical Cases, 16(6), 212-221. https://doi.org/10.14740/jmc5136